Preview Mode Links will not work in preview mode

Feb 8, 2025

Featuring an interview with Dr Seth Wander, including the following topics:

  • Therapy selection after CDK4/6 inhibitor failure: A review of current and investigational treatment for HR-positive, HER2-negative breast cancer
    • Astore S et al. A therapeutic algorithm guiding subsequent therapy selection after CDK4/6...


Jan 31, 2025

Featuring an interview with Dr Seth Wander, including the following topics:

  • The clinical utility of ESR1 mutations in HR-positive, HER2-negative advanced breast cancer
    • Grinshpun A et al. The clinical utility of ESR1 mutations in hormone receptor-positive, HER2-negative advanced breast cancer. Hematol Oncol Clin...


Jan 24, 2025

Featuring perspectives from Dr Lisa Carey and Dr Rita Nanda, including the following topics:

  • Introduction (0:00)
  • Patient Videos and Clinical Investigator Survey (3:26)
  • San Antonio Breast Cancer Symposium (SABCS®) Report — Education Session on Antibody-Drug Conjugates (26:03)
  • Patient Videos and Clinical...


Jan 17, 2025

Featuring perspectives from Dr Lisa A Carey and Dr Rita Nanda, including the following topics: 

  • Introduction (0:00)
  • Stages of Triple-Negative Breast Cancer (TNBC); Recurrence After Adjuvant Treatment (5:28)
  • Long-Term Outcomes with Metastatic TNBC (11:55)
  • Side Effects and Complications of Treatment (24:42)
  • Dose...


Jan 10, 2025

Featuring perspectives from Dr Erika Hamilton, Dr Kevin Kalinsky, Dr Ian E Krop, Dr Joyce O’Shaughnessy and Dr Sara M Tolaney, including the following topics:

  • Introduction (0:00)
  • Optimizing the Care of Patients with HER2-Positive Metastatic Breast Cancer (mBC) — Dr Krop (10:17)
  • Selection and Sequencing of Therapy...